img

Global Plasma-derived Therapies Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Plasma-derived Therapies Market Insights, Forecast to 2034

Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.
Market Analysis and InsightsGlobal Plasma-derived Therapies Market
Global Plasma-derived Therapies market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Plasma-derived Therapies industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Plasma-derived Therapies market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Plasma-derived Therapies market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
Segment by Type
Albumin
Immunoglobulin
Factor VIII
Others

Segment by Application


Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Plasma-derived Therapies introduction, etc. Plasma-derived Therapies Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of Plasma-derived Therapies
Chapter 13Methodology and Data Sources adopted by MRA Research

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma-derived Therapies Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Factor VIII
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma-derived Therapies Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Hemophilia
1.3.3 Primary Immunodeficiencies (PIDs)
1.3.4 Idiopathic Thrombocytopenic Purpura (ITP)
1.3.5 COVID-19
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma-derived Therapies Market Perspective (2018-2033)
2.2 Global Plasma-derived Therapies Growth Trends by Region
2.2.1 Plasma-derived Therapies Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Plasma-derived Therapies Historic Market Size by Region (2018-2023)
2.2.3 Plasma-derived Therapies Forecasted Market Size by Region (2024-2033)
2.3 Plasma-derived Therapies Market Dynamics
2.3.1 Plasma-derived Therapies Industry Trends
2.3.2 Plasma-derived Therapies Market Drivers
2.3.3 Plasma-derived Therapies Market Challenges
2.3.4 Plasma-derived Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Plasma-derived Therapies by Players
3.1.1 Global Plasma-derived Therapies Revenue by Players (2018-2023)
3.1.2 Global Plasma-derived Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Plasma-derived Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Plasma-derived Therapies, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global Plasma-derived Therapies Market Concentration Ratio
3.4.1 Global Plasma-derived Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma-derived Therapies Revenue in 2023
3.5 Global Key Players of Plasma-derived Therapies Head office and Area Served
3.6 Global Key Players of Plasma-derived Therapies, Product and Application
3.7 Global Key Players of Plasma-derived Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma-derived Therapies Breakdown Data by Type
4.1 Global Plasma-derived Therapies Historic Market Size by Type (2018-2023)
4.2 Global Plasma-derived Therapies Forecasted Market Size by Type (2024-2033)
5 Plasma-derived Therapies Breakdown Data by Application
5.1 Global Plasma-derived Therapies Historic Market Size by Application (2018-2023)
5.2 Global Plasma-derived Therapies Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Plasma-derived Therapies Market Size (2018-2033)
6.2 North America Plasma-derived Therapies Market Size by Type
6.2.1 North America Plasma-derived Therapies Market Size by Type (2018-2023)
6.2.2 North America Plasma-derived Therapies Market Size by Type (2024-2033)
6.2.3 North America Plasma-derived Therapies Market Share by Type (2018-2033)
6.3 North America Plasma-derived Therapies Market Size by Application
6.3.1 North America Plasma-derived Therapies Market Size by Application (2018-2023)
6.3.2 North America Plasma-derived Therapies Market Size by Application (2024-2033)
6.3.3 North America Plasma-derived Therapies Market Share by Application (2018-2033)
6.4 North America Plasma-derived Therapies Market Size by Country
6.4.1 North America Plasma-derived Therapies Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America Plasma-derived Therapies Market Size by Country (2018-2023)
6.4.3 North America Plasma-derived Therapies Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Plasma-derived Therapies Market Size (2018-2033)
7.2 Europe Plasma-derived Therapies Market Size by Type
7.2.1 Europe Plasma-derived Therapies Market Size by Type (2018-2023)
7.2.2 Europe Plasma-derived Therapies Market Size by Type (2024-2033)
7.2.3 Europe Plasma-derived Therapies Market Share by Type (2018-2033)
7.3 Europe Plasma-derived Therapies Market Size by Application
7.3.1 Europe Plasma-derived Therapies Market Size by Application (2018-2023)
7.3.2 Europe Plasma-derived Therapies Market Size by Application (2024-2033)
7.3.3 Europe Plasma-derived Therapies Market Share by Application (2018-2033)
7.4 Europe Plasma-derived Therapies Market Size by Country
7.4.1 Europe Plasma-derived Therapies Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe Plasma-derived Therapies Market Size by Country (2018-2023)
7.4.3 Europe Plasma-derived Therapies Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Plasma-derived Therapies Market Size (2018-2033)
8.2 China Plasma-derived Therapies Market Size by Type
8.2.1 China Plasma-derived Therapies Market Size by Type (2018-2023)
8.2.2 China Plasma-derived Therapies Market Size by Type (2024-2033)
8.2.3 China Plasma-derived Therapies Market Share by Type (2018-2033)
8.3 China Plasma-derived Therapies Market Size by Application
8.3.1 China Plasma-derived Therapies Market Size by Application (2018-2023)
8.3.2 China Plasma-derived Therapies Market Size by Application (2024-2033)
8.3.3 China Plasma-derived Therapies Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Plasma-derived Therapies Market Size (2018-2033)
9.2 Asia Plasma-derived Therapies Market Size by Type
9.2.1 Asia Plasma-derived Therapies Market Size by Type (2018-2023)
9.2.2 Asia Plasma-derived Therapies Market Size by Type (2024-2033)
9.2.3 Asia Plasma-derived Therapies Market Share by Type (2018-2033)
9.3 Asia Plasma-derived Therapies Market Size by Application
9.3.1 Asia Plasma-derived Therapies Market Size by Application (2018-2023)
9.3.2 Asia Plasma-derived Therapies Market Size by Application (2024-2033)
9.3.3 Asia Plasma-derived Therapies Market Share by Application (2018-2033)
9.4 Asia Plasma-derived Therapies Market Size by Region
9.4.1 Asia Plasma-derived Therapies Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia Plasma-derived Therapies Market Size by Region (2018-2023)
9.4.3 Asia Plasma-derived Therapies Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Type
10.2.1 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Plasma-derived Therapies Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Application
10.3.1 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Plasma-derived Therapies Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Country
10.4.1 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 CSL Behring LLC
11.1.1 CSL Behring LLC Company Details
11.1.2 CSL Behring LLC Business Overview
11.1.3 CSL Behring LLC Plasma-derived Therapies Introduction
11.1.4 CSL Behring LLC Revenue in Plasma-derived Therapies Business (2018-2023)
11.1.5 CSL Behring LLC Recent Developments
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Shire Business Overview
11.2.3 Shire Plasma-derived Therapies Introduction
11.2.4 Shire Revenue in Plasma-derived Therapies Business (2018-2023)
11.2.5 Shire Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Plasma-derived Therapies Introduction
11.3.4 Bayer Revenue in Plasma-derived Therapies Business (2018-2023)
11.3.5 Bayer Recent Developments
11.4 Kedrion
11.4.1 Kedrion Company Details
11.4.2 Kedrion Business Overview
11.4.3 Kedrion Plasma-derived Therapies Introduction
11.4.4 Kedrion Revenue in Plasma-derived Therapies Business (2018-2023)
11.4.5 Kedrion Recent Developments
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Plasma-derived Therapies Introduction
11.5.4 Takeda Revenue in Plasma-derived Therapies Business (2018-2023)
11.5.5 Takeda Recent Developments
11.6 Biotest
11.6.1 Biotest Company Details
11.6.2 Biotest Business Overview
11.6.3 Biotest Plasma-derived Therapies Introduction
11.6.4 Biotest Revenue in Plasma-derived Therapies Business (2018-2023)
11.6.5 Biotest Recent Developments
11.7 Octaparma
11.7.1 Octaparma Company Details
11.7.2 Octaparma Business Overview
11.7.3 Octaparma Plasma-derived Therapies Introduction
11.7.4 Octaparma Revenue in Plasma-derived Therapies Business (2018-2023)
11.7.5 Octaparma Recent Developments
11.8 Bio Products Laboratory (BPL)
11.8.1 Bio Products Laboratory (BPL) Company Details
11.8.2 Bio Products Laboratory (BPL) Business Overview
11.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Introduction
11.8.4 Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2018-2023)
11.8.5 Bio Products Laboratory (BPL) Recent Developments
11.9 LFB
11.9.1 LFB Company Details
11.9.2 LFB Business Overview
11.9.3 LFB Plasma-derived Therapies Introduction
11.9.4 LFB Revenue in Plasma-derived Therapies Business (2018-2023)
11.9.5 LFB Recent Developments
11.10 Grifols
11.10.1 Grifols Company Details
11.10.2 Grifols Business Overview
11.10.3 Grifols Plasma-derived Therapies Introduction
11.10.4 Grifols Revenue in Plasma-derived Therapies Business (2018-2023)
11.10.5 Grifols Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Plasma-derived Therapies Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Albumin
Table 3. Key Players of Immunoglobulin
Table 4. Key Players of Factor VIII
Table 5. Key Players of Others
Table 6. Global Plasma-derived Therapies Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 7. Global Plasma-derived Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 8. Global Plasma-derived Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Plasma-derived Therapies Market Share by Region (2018-2023)
Table 10. Global Plasma-derived Therapies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Plasma-derived Therapies Market Share by Region (2024-2033)
Table 12. Plasma-derived Therapies Market Trends
Table 13. Plasma-derived Therapies Market Drivers
Table 14. Plasma-derived Therapies Market Challenges
Table 15. Plasma-derived Therapies Market Restraints
Table 16. Global Plasma-derived Therapies Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Plasma-derived Therapies Revenue Share by Players (2018-2023)
Table 18. Global Top Plasma-derived Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Therapies as of 2023)
Table 19. Global Plasma-derived Therapies Industry Ranking 2021 VS 2023 VS 2023
Table 20. Global 5 Largest Players Market Share by Plasma-derived Therapies Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Plasma-derived Therapies, Headquarters and Area Served
Table 22. Global Key Players of Plasma-derived Therapies, Product and Application
Table 23. Global Key Players of Plasma-derived Therapies, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma-derived Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Plasma-derived Therapies Revenue Market Share by Type (2018-2023)
Table 27. Global Plasma-derived Therapies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Plasma-derived Therapies Revenue Market Share by Type (2024-2033)
Table 29. Global Plasma-derived Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Plasma-derived Therapies Revenue Share by Application (2018-2023)
Table 31. Global Plasma-derived Therapies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Plasma-derived Therapies Revenue Share by Application (2024-2033)
Table 33. North America Plasma-derived Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Plasma-derived Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Plasma-derived Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Plasma-derived Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Plasma-derived Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 38. North America Plasma-derived Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Plasma-derived Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Plasma-derived Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Plasma-derived Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Plasma-derived Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Plasma-derived Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Plasma-derived Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Europe Plasma-derived Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Plasma-derived Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Plasma-derived Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Plasma-derived Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Plasma-derived Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Plasma-derived Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Plasma-derived Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Plasma-derived Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Plasma-derived Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Plasma-derived Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Plasma-derived Therapies Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 56. Asia Plasma-derived Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Plasma-derived Therapies Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Plasma-derived Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 63. Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Plasma-derived Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 65. CSL Behring LLC Company Details
Table 66. CSL Behring LLC Business Overview
Table 67. CSL Behring LLC Plasma-derived Therapies Product
Table 68. CSL Behring LLC Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 69. CSL Behring LLC Recent Developments
Table 70. Shire Company Details
Table 71. Shire Business Overview
Table 72. Shire Plasma-derived Therapies Product
Table 73. Shire Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 74. Shire Recent Developments
Table 75. Bayer Company Details
Table 76. Bayer Business Overview
Table 77. Bayer Plasma-derived Therapies Product
Table 78. Bayer Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 79. Bayer Recent Developments
Table 80. Kedrion Company Details
Table 81. Kedrion Business Overview
Table 82. Kedrion Plasma-derived Therapies Product
Table 83. Kedrion Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 84. Kedrion Recent Developments
Table 85. Takeda Company Details
Table 86. Takeda Business Overview
Table 87. Takeda Plasma-derived Therapies Product
Table 88. Takeda Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 89. Takeda Recent Developments
Table 90. Biotest Company Details
Table 91. Biotest Business Overview
Table 92. Biotest Plasma-derived Therapies Product
Table 93. Biotest Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 94. Biotest Recent Developments
Table 95. Octaparma Company Details
Table 96. Octaparma Business Overview
Table 97. Octaparma Plasma-derived Therapies Product
Table 98. Octaparma Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 99. Octaparma Recent Developments
Table 100. Bio Products Laboratory (BPL) Company Details
Table 101. Bio Products Laboratory (BPL) Business Overview
Table 102. Bio Products Laboratory (BPL) Plasma-derived Therapies Product
Table 103. Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 104. Bio Products Laboratory (BPL) Recent Developments
Table 105. LFB Company Details
Table 106. LFB Business Overview
Table 107. LFB Plasma-derived Therapies Product
Table 108. LFB Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 109. LFB Recent Developments
Table 110. Grifols Company Details
Table 111. Grifols Business Overview
Table 112. Grifols Plasma-derived Therapies Product
Table 113. Grifols Revenue in Plasma-derived Therapies Business (2018-2023) & (US$ Million)
Table 114. Grifols Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma-derived Therapies Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global Plasma-derived Therapies Market Share by Type: 2023 VS 2033
Figure 3. Albumin Features
Figure 4. Immunoglobulin Features
Figure 5. Factor VIII Features
Figure 6. Others Features
Figure 7. Global Plasma-derived Therapies Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 8. Global Plasma-derived Therapies Market Share by Application: 2023 VS 2033
Figure 9. Hemophilia Case Studies
Figure 10. Primary Immunodeficiencies (PIDs) Case Studies
Figure 11. Idiopathic Thrombocytopenic Purpura (ITP) Case Studies
Figure 12. COVID-19 Case Studies
Figure 13. Others Case Studies
Figure 14. Plasma-derived Therapies Report Years Considered
Figure 15. Global Plasma-derived Therapies Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Plasma-derived Therapies Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 17. Global Plasma-derived Therapies Market Share by Region: 2023 VS 2033
Figure 18. Global Plasma-derived Therapies Market Share by Players in 2023
Figure 19. Global Top Plasma-derived Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Therapies as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Plasma-derived Therapies Revenue in 2023
Figure 21. North America Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Plasma-derived Therapies Market Share by Type (2018-2033)
Figure 23. North America Plasma-derived Therapies Market Share by Application (2018-2033)
Figure 24. North America Plasma-derived Therapies Market Share by Country (2018-2033)
Figure 25. United States Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Plasma-derived Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Plasma-derived Therapies Market Share by Type (2018-2033)
Figure 29. Europe Plasma-derived Therapies Market Share by Application (2018-2033)
Figure 30. Europe Plasma-derived Therapies Market Share by Country (2018-2033)
Figure 31. Germany Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Plasma-derived Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Plasma-derived Therapies Market Share by Type (2018-2033)
Figure 39. China Plasma-derived Therapies Market Share by Application (2018-2033)
Figure 40. Asia Plasma-derived Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Plasma-derived Therapies Market Share by Type (2018-2033)
Figure 42. Asia Plasma-derived Therapies Market Share by Application (2018-2033)
Figure 43. Asia Plasma-derived Therapies Market Share by Region (2018-2033)
Figure 44. Japan Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Plasma-derived Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Plasma-derived Therapies Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Plasma-derived Therapies Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Plasma-derived Therapies Market Share by Country (2018-2033)
Figure 54. Brazil Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Plasma-derived Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. CSL Behring LLC Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 61. Shire Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 62. Bayer Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 63. Kedrion Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 64. Takeda Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 65. Biotest Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 66. Octaparma Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 67. Bio Products Laboratory (BPL) Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 68. LFB Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 69. Grifols Revenue Growth Rate in Plasma-derived Therapies Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries